Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

JOHNSON & JOHNSON

(JNJ)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Johnson & Johnson : Covid-19 - Angola Receives 40,000 Doses Sputnik Vaccine

05/14/2021 | 11:06am EDT

Angola has received 40,000 doses of Russian Sputnik vaccine, Angop has learnt

The fact was confirmed by National Director of Public Health, Helga Freitas, on Wednesday, stating that the batch is part of 12 million doses of the Sputnik vaccine.

Six million people are expected to get sputnik vaccine.

The Angolan Executive will also receive than four million Johnson & Johnson and more than one million Pfizer vaccine, Helga Freitas has told the press.

Professionals in the banking sector, General Tax Administration (AGT), are among the priority group.

The national plan foresees to cover about 54% of the population, a total of 16.8 million, aged over 16.

So far, the country has received more than one million doses of the Astrazeneca and sinopharma vaccine.

The fact was confirmed by National Director of Public Health, Helga Freitas, on Wednesday, stating that the batch is part of 12 million doses of the Sputnik vaccine.

Six million people are expected to get sputnik vaccine.

The Angolan Executive will also receive than four million Johnson & Johnson and more than one million Pfizer vaccine, Helga Freitas has told the press.

Professionals in the banking sector, General Tax Administration (AGT), are among the priority group.

The national plan foresees to cover about 54% of the population, a total of 16.8 million, aged over 16.

So far, the country has received more than one million doses of the Astrazeneca and sinopharma vaccine.

Copyright Angola Press Agency. Distributed by AllAfrica Global Media (allAfrica.com)., source News Service English

Stocks mentioned in the article
ChangeLast1st jan.
JOHNSON & JOHNSON -1.96% 161.98 Delayed Quote.2.92%
PFIZER, INC. -1.70% 38.81 Delayed Quote.5.43%
All news about JOHNSON & JOHNSON
06/19MODERNAá : U.S. administers more than 317 mln doses of COVID-19 vaccines - CDC
RE
06/18The Week Ahead -- Barron's
DJ
06/17JOHNSON & JOHNSONá : Eying border reopening, Mexico begins J&J vaccine rollout i..
AQ
06/17Canada Vaccine Panel Recommends Against AstraZeneca PLC for Second Dose
DJ
06/17US to Spend $3.2 Billion on COVID Treatments Research
MT
06/16ASTRAZENECAá : Second Phase of Covid-19 Vaccinations Begins
AQ
06/16EU Says Johnson & Johnson May Not Meet Vaccine Supply Commitment After Jabs C..
MT
06/15US, EU Vow to Provide COVID-19 Vaccine to Two-Thirds of World's Population by..
MT
06/15JOHNSON & JOHNSONá : Aspen to Dispatch 300 000 J&J Vaccines for Teachers
AQ
06/15JOHNSON & JOHNSONá : Donated US vaccines arrive for Mexican border cities
AQ
More news
Financials (USD)
Sales 2021 92 812 M - -
Net income 2021 22 227 M - -
Net Debt 2021 314 M - -
P/E ratio 2021 19,5x
Yield 2021 2,58%
Capitalization 427 B 427 B -
EV / Sales 2021 4,60x
EV / Sales 2022 4,30x
Nbr of Employees 134 500
Free-Float 84,3%
Chart JOHNSON & JOHNSON
Duration : Period :
Johnson & Johnson Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends JOHNSON & JOHNSON
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 21
Average target price 183,67 $
Last Close Price 161,98 $
Spread / Highest target 25,9%
Spread / Average Target 13,4%
Spread / Lowest Target -2,46%
EPS Revisions
Managers and Directors
NameTitle
Alex Gorsky Chairman & Chief Executive Officer
Joseph J. Wolk Chief Financial Officer & Executive Vice President
Paulus Stoffels Chief Scientific Officer
James D. Swanson Global Chief Information Officer & Executive VP
Charles O. Prince Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
JOHNSON & JOHNSON2.92%426 557
ROCHE HOLDING AG12.70%325 803
PFIZER, INC.5.43%217 246
NOVARTIS AG2.47%208 642
ABBVIE INC.5.57%199 795
ELI LILLY AND COMPANY29.44%198 668